CSIMarket
 
Silk Road Medical Inc   (NASDAQ: SILK)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 40
 Employees 474
 Revenues (TTM) (Millions $) 190
 Net Income (TTM) (Millions $) -57
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 2

Business Description


Silk Road Medical Inc is a medical technology company that specializes in developing and commercializing novel devices and treatment options for patients suffering from vascular diseases. It was founded in Silicon Valley in 2007, and has rapidly risen to become a trusted brand in the healthcare industry.

The company's flagship product is the ENROUTEe Transcarotid Stent System, which is used to treat carotid artery disease, a potentially deadly condition that can lead to stroke. The ENROUTEe technology offers a minimally invasive solution for patients that enables the treatment of carotid artery disease without the need for open surgery.

The Silk Road Medical team comprises world-renowned experts in vascular surgery, interventional cardiology, and biomedical engineering. The company's research is backed by a comprehensive intellectual property portfolio that includes patents, trade secrets, and trademarks.

Silk Road Medical has established a global network of distribution partners to ensure that its medical devices reach the widest possible audience. The company has commercial offices in Europe and Asia, as well as in the United States. Additionally, Silk Road Medical has a robust digital platform that allows physicians and patients to access medical information, clinical studies, and educational resources.

The company has received numerous accolades for its innovation, including the Scientific Achievement Award from the Society for Vascular Surgery. Silk Road Medical has also been recognized by major publications such as Forbes and Inc. Magazine for its growth and impact on the healthcare industry.

In summary, Silk Road Medical Inc is a highly respected medical technology company that is dedicated to improving the lives of patients with vascular diseases through innovative solutions, advanced research, and education.


   Company Address: 1213 Innsbruck Dr. Sunnyvale 94089 CA
   Company Phone Number: 720-9002   Stock Exchange / Ticker: NASDAQ SILK


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX   -5.91%    
BDX   -5.92%    
BSX   -10.9%    
MDT   -0.61%    
SYK   -13.51%    
ZBH   -7.1%    
• View Complete Report
   



Management Announcement

Silk Road Medical Celebrates 100,000 Transcarotid Artery Revascularization (TCAR) Procedures, Reinforcing Leadership in Minimally Invasive Vascular Interventions

Published Tue, Jul 30 2024 12:00 PM UTC

Silk Road Medical: Revolutionizing Transcarotid Artery Revascularization with Groundbreaking Milestone of 100,000 Procedures
Study-backed and supported by extensive clinical publications, Silk Road Medical Inc has once again proven its expertise in delivering positive outcomes through its innovative Transcarotid Artery Revascularization (TCAR) procedures. This milestone...

Product Service News

Augmenting Stroke Prevention: Silk Road Medical Unveils Advanced Neuroprotection System for TCAR Procedures

Published Tue, Apr 2 2024 8:30 PM UTC

Silk Road Medical Enhances TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSSUNNYVALE, Calif., April 02, 2024 - Silk Road Medical, Inc. (Nasdaq: SILK), a leading company dedicated to reducing the risk of stroke and its detrimental consequences, has recently unveiled its latest innovation, the ENROUTE Transcarotid Neuroprotection System PLUS (NPS ...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 5.45
Working Capital Ratio 7.63
Leverage Ratio (MRQ) 0.74
Total Debt to Equity 0.49
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.45 $
Revenues (TTM) 4.79 $
Cash Flow (TTM) -
Cash 4.34 $
Book Value 3.9 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 400,143
Net Income per Employee (TTM) -119,278
Receivable Turnover Ratio (TTM) 7.68
Inventory Turnover Ratio (TTM) 1.69
Asset Turnover Ratio (TTM) 0.72

Profitability Ratios Current
Gross Margin (MRQ) 76.24 %
Operating Margin (MRQ) -34.05 %
Net Margin (MRQ) -32.87 %
Net Cash Flow Margin (MRQ) 0.02 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -


  Silk Road Medical Inc Outlook

On February 28 2024 the Silk Road Medical Inc provided following guidance


In the fourth quarter of 2023, Silk Road Medical reported a significant increase in revenue, with total revenue reaching a record high for the company. The company's focus on reducing the risk of stroke has clearly resonated with customers, leading to a strong performance in sales.

For the full year of 2023, Silk Road Medical also saw positive results, with steady growth in revenue and an increase in market share. The company's commitment to providing innovative medical solutions for stroke prevention has positioned them as a leader in the industry.

Looking ahead to 2024, Silk Road Medical is optimistic about future growth and profitability. The company has provided financial estimates for ...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.